Lupin Limited has informed the Exchange regarding a press release dated November 08, 2025, titled "Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After SuccessfulInspection and Assessment".
Press Release Nov 08 2025
Filed with NSE · · 2 pages · English
Release
Earlier from Lupin
- Press Release Nov 06 2025
- Press Release Nov 05 2025
- Press Release Oct 30 2025
- Press Release Oct 28 2025
- Governor Murphy and Local Leaders Attend Ribbon-Cutting Ceremony, Marking the Inauguration of Lupin's New Corporate Offices in Bridgewater
Later from Lupin
- Press Release Nov 12 2025
- Press Release Nov 13 2025
- Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™
- Press Release Nov 14 2025
- Press Release Nov 15 2025
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin